GSG GENII Software Group acquires iVention
GSG GENII Software Group announces that it has completed the acquisition of iVention. iVention provides laboratories in a wide range of industries with its powerful and flexible iVention Lab Execution System (iLES), a software system designed specifically for and around the laboratory process. Based in Zwolle, The Netherlands, iVention deploys its solutions via its Cloud Based Laboratory Automation Platform that combines all essential lab automation features in a single system.
Symbolic image
Computer-generated image
As the ultimate laboratory management tool iLES improves efficiency and quality by streamlining workflows and managing and computerizing both research and routine work – even in highly regulated environments. With iLES, laboratories benefit from automatic updates, unlock real-time information, ensure data integrity and regulatory compliance, while saving time and cost by efficient process automation and reduced manual data handling.
iVention becomes part of GENII’s Laboratories business unit, joining other specialists such as ICD and Blomesystem as GENII continues to build out its clinical and non-clinical software solutions for the laboratory sector. As part of a larger Laboratories business, iVention will leverage GENII’s Laboratories customer base and geographical footprint, receiving investment to achieve its ambition of becoming a global top 5 iLES solution, competing directly with incumbent players and winning market share as the modern application of choice.
Oscar Kox, iVention CEO, said, “We are delighted to join GENII and its Laboratories team. GENII is very committed to this sector, and the opportunity to become part of this, utilising our iLES technology platform across this vertical is very exciting. I believe we are stronger together, and our combined industry expertise and best-in-class product will enable us to shape the advanced, automated technology era for labs over the coming years.”
Matthias Siekmann, Group CEO, GENII, stated, “Our acquisition of iVention further progresses GENII’s strategy of being the best home for market-leading, niche enterprise software businesses. Together we will make a strong push to change the lab automation world and establish iVention as a leading product with the most modern technology, future-proofed and financially backed by GENII.”
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Digitalization in the laboratory
The topic world Digitalization in the lab presents innovations and trends from digital data systems (ELN, LIMS) to laboratory robots and networked devices (IoT) to AI and machine learning.
Topic world Digitalization in the laboratory
The topic world Digitalization in the lab presents innovations and trends from digital data systems (ELN, LIMS) to laboratory robots and networked devices (IoT) to AI and machine learning.